Working… Menu

Study to Evaluate Efficacy, Safety, and Tolerability of MT‑7117 in Subjects With Erythropoietic Protoporphyria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03520036
Recruitment Status : Active, not recruiting
First Posted : May 9, 2018
Last Update Posted : April 30, 2019
Information provided by (Responsible Party):
Mitsubishi Tanabe Pharma Development America, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : December 2019